| [1] |
Yin Z, Liu C, Chen Y, et al. Timing of hepatectomy in resectable synchronous colorectal liver metastases (SCRLM): simultaneous or delayed?[J]. Hepatology, 2013, 57(6):2346-2357.
|
| [2] |
中华医学会外科学分会胃肠外科学组，结直肠肛门外科学组，中国抗癌协会大肠癌专业委员会．结直肠癌肝转移诊断和综合治疗指南(草案)[J]．中华胃肠外科杂志，2008, 11(5):501-504.
|
| [3] |
中华医学会外科学分会胃肠外科学组，结直肠肛门外科学组，中国抗癌协会大肠癌专业委员会．结直肠癌肝转移诊断和综合治疗指南(草案)[J]．中华胃肠外科杂志，2008, 11(6):597-602.
|
| [4] |
中华医学会外科学分会胃肠外科学组，中华医学会外科学分会结直肠肛门外科学组，中国抗癌协会大肠癌专业委员会．结直肠癌肝转移诊断和综合治疗指南(V 2010)[J]．中华胃肠外科杂志，2010, 13(6):457-470.
|
| [5] |
中华医学会外科学分会胃肠外科学组，中华医学会外科学分会结直肠肛门外科学组，中国抗癌协会大肠癌专业委员会，等．结直肠癌肝转移诊断和综合治疗指南(V 2013)[J]．中华胃肠外科杂志，2013, 16(8):780-788.
|
| [6] |
周俭，黄成，樊嘉．肝移植相关技术在复杂肝脏肿瘤切除术中的应用[J/CD]．中华肝脏外科手术学电子杂志，2012, 1(3):147-150.
|
| [7] |
Knijn N, de Ridder JA, Punt CJ, et al. Histopathological evaluation of resected colorectal cancer liver metastases: what should be done? [J]. Histopathology, 2013, 63(2):149-156.
|
| [8] |
Chua TC, Saxena A, Liauw W, et al. Hepatectomy and resection of concomitant extrahepatic disease for colorectal liver metastases: a systematic review[J]. Eur J Cancer, 2012, 48(12):1757-1765.
|
| [9] |
Jones RP, Vauthey JN, Adam R, et al. Effect of specialist decision-making on treatment strategies for colorectal liver metastases[J]. Br J Surg, 2012, 99(9):1263-1269.
|
| [10] |
Wicherts DA, de Haas RJ, Salloum C, et al. Repeat hepatectomy for recurrent colorectal metastases[J]. Br J Surg, 2013, 100(6):808-818.
|
| [11] |
Hagness M, Foss A, Line PD, et al. Liver transplantation for nonresectable liver metastases from colorectal cancer[J]. Ann Surg, 2013, 257(5):800-806.
|
| [12] |
Viganò L, Capussotti L, De Rosa G, et al. Liver resection for colorectal metastases after chemotherapy: impact of chemotherapy-related liver injuries, pathological tumor response, and micrometastases on long-term survival[J]. Ann Surg, 2013, 258(5):731-740.
|
| [13] |
Nordlinger B, Sorbye H, Glimelius B, et al. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial[J]. Lancet, 2008, 371(9617):1007-1016.
|
| [14] |
Gur I, Diggs BS, Wagner JA, et al. Safety and outcomes following resection of colorectal liver metastases in the era of current perioperative chemotherapy[J]. J Gastrointest Surg, 2013, 17(12):2133-2142.
|
| [15] |
Gallagher DJ, Zheng J, Capanu M, et al. Response to neoadjuvant chemotherapy does not predict overall survival for patients with synchronous colorectal hepatic metastases[J]. Ann Surg Oncol, 2009, 16(7):1844-1851.
|
| [16] |
Bischof DA, Clary BM, Maithel SK, et al. Surgical management of disappearing colorectal liver metastases[J]. Br J Surg, 2013, 100(11):1414-1420.
|
| [17] |
Nordlinger B, Sorbye H, Glimelius B, et al. Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial[J]. Lancet Oncol, 2013, 14(12):1208-1215.
|
| [18] |
Jones RP, Malik HZ, Fenwick SW, et al. Perioperative chemotherapy for resectable colorectal liver metastases: where now? [J]. Eur J Surg Oncol, 2013, 39(8):807-811.
|
| [19] |
Hirokawa F, Hayashi M, Miyamoto Y, et al. Reconsideration of the indications for adjuvant chemotherapy for liver metastases from colorectal cancer after initial hepatectomy[J]. Ann Surg Oncol, 2014, 21(1):139-146.
|
| [20] |
Galizia G, De Vita F, Lieto E, et al. Conversion chemotherapy followed by hepatic resection in colorectal cancer with initially unresectable liver-limited metastases[J]. Oncol Rep, 2013, 30(6):2992-2998.
|
| [21] |
Wagman LD. Importance of response to neoadjuvant therapy in patients with liver-limited mCRC when the intent is resection and/or ablation[J]. Clin Colorectal Cancer, 2013, 12(4):223-232.
|
| [22] |
Adam R, De Gramont A, Figueras J, et al. The oncosurgery approach to managing liver metastases from colorectal cancer: a multidisciplinary international consensus[J]. Oncologist, 2012, 17(10):1225-1239.
|
| [23] |
Schnitzbauer AA, Lang SA, Goessmann H, et al. Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings[J]. Ann Surg, 2012, 255(3):405-414.
|
| [24] |
Slesser AA, Chand M, Goldin R, et al. Outcomes of simultaneous resections for patients with synchronous colorectal liver metastases[J]. Eur J Surg Oncol, 2013, 39(12):1384-1393.
|
| [25] |
Neumann UP, Seehofer D, Neuhaus P. The surgical treatment of hepatic metastases in colorectal carcinoma[J]. Dtsch Arztebl Int, 2010, 107(19):335-342.
|
| [26] |
Jegatheeswaran S, Mason JM, Hancock HC, et al. The liver-first approach to the management of colorectal cancer with synchronous hepatic metastases: a systematic review[J]. JAMA Surg, 2013, 148(4):385-391.
|
| [27] |
De Rosa A, Gomez D, Brooks A, et al. "Liver-first" approach for synchronous colorectal liver metastases: is this a justifiable approach?[J]. J Hepatobiliary Pancreat Sci, 2013, 20(3):263-270.
|
| [28] |
Mocellin S, Pilati P, Lise M, et al. Meta-analysis of hepatic arterial infusion for unresectable liver metastases from colorectal cancer: the end of an era?[J]. J Clin Oncol, 2007, 25(35):5649-5654.
|
| [29] |
Karanicolas PJ, Jarnagin WR, Gonen M, et al. Long-term outcomes following tumor ablation for treatment of bilateral colorectal liver metastases[J]. JAMA Surg, 2013, 148(7):597-601.
|
| [30] |
Ruers T, Punt C, Van Coevorden F, et al. Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004)[J]. Ann Oncol, 2012, 23(10):2619-2626.
|
| [31] |
Otto G, Düber C, Hoppe-Lotichius M, et al. Radiofrequency ablation as first-line treatment in patients with early colorectal liver metastases amenable to surgery[J]. Ann Surg, 2010, 251(5):796-803.
|
| [32] |
Weng M, Zhang Y, Zhou D, et al. Radiofrequency ablation versus resection for colorectal cancer liver metastases: a meta-analysis[J]. PLoS One, 2012, 7(9):e45493.
|